Please ensure Javascript is enabled for purposes of website accessibility

todd blanche

Apr 23, 2026

US reclassifies certain marijuana products as a less-dangerous drug

The U.S. Department of Justice reschedules FDA-approved and state-licensed marijuana from Schedule I to Schedule III, easing research and industry restrictions.

Verdicts & Settlements

See All Verdicts & Settlements

Opinion Digests

See All Digests